Dr. / Dr Alexander Koven
Sensitivity and specificity of renal mass biopsy for small renal masses using repeat biopsy as a pathological surrogate to nephrectomy

Mr. / M. Ghady Bou-Nehme Sawaya
Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) with or without sarcomatoid differentiation treated with systemic therapy in real-world Canadian setting

Dr. / Dr Félix Couture
Evolution of BIIF renal cysts and the impact of the 2019 Bosniak classification

Dr. / Dr Francis Lemire
Comparison of 99mTc-DTPA plasma clearance and estimated glomerular filtration rate in the renal hypothermia trial

Dr. / Dr Raees Cassim
A prospective randomized parallel-controlled pilot trial of stereotactic body radiation therapy vs. radiofrequency ablation for the management of small renal masses

Dr. / Dr Douglas Cheung
A matched analysis of active surveillance versus nephrectomy for small renal masses

Dr. / Dr Kristen McAlpine
Surgeon-level versus hospital-level quality variance in kidney cancer surgery

Dr. / Dr Ricardo A. Rendon
Outcomes of partial nephrectomy for non-metastatic cT2 renal tumors: results from a Canadian multi-institutional collaborative

Dr. / Dr Douglas Cheung
Intermediate term outcomes for active surveillance of biopsy-proven oncocytomas

Dr. / Dr Michael J Uy
Long-term evaluation of recurrence in patients undergoing radiofrequency ablation for renal tumours

Dr. / Dr Ahmed Kotb
Partial nephrectomy for large renal masses: lessons we learned

Dr. / Dr Noah Stern
Surgical treatment of tumors involving horseshoe kidneys

Mr. / M. Ahmed Shoeib
Proportion of malignant masses in newly included Bosniak version 2019 class 2 cystic renal masses: a systematic review

Dr. / Dr Noah Stern
Percutaneous ablation versus partial nephrectomy for clinical T1a renal masses

Dr. / Dr Thomas Southall
The historical origins and contemporary role of endoluminal treatment for urethral stricture disease